General Information of the Compound
Compound ID
CP0014703
Compound Name
8-[5-(difluoromethyl)pyridin-3-yl]-1-(oxan-4-yl)-2H-pyrazolo[3,4-c]quinoline
    Show/Hide
Formula
C21H18F2N4O
Molecular Weight
380.398
Canonical SMILES
FC(F)c1cncc(c1)-c1ccc2ncc3[nH]nc(C4CCOCC4)c3c2c1
    Show/Hide
InChI
InChI=1S/C21H18F2N4O/c22-21(23)15-7-14(9-24-10-15)13-1-2-17-16(8-13)19-18(11-25-17)26-27-20(19)12-3-5-28-6-4-12/h1-2,7-12,21H,3-6H2,(H,26,27)
    Show/Hide
InChIKey
HXIMOOZRCPTJDQ-UHFFFAOYSA-N
Physicochemical Property
logP
5.0047
Rotatable Bonds
3
Heavy Atom Count
28
Polar Areas
63.69
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4869632
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000154 HEK293-EBNA1-6E Homo sapiens (Human)  1
1
IC50 = 3440 nM
   TI
   LI
   LO
   TS